New Study Reveals Abortion Pill 22x More Dangerous Than FDA Reports

A new study from the Ethics and Public Policy Center (EPPC) has uncovered alarming findings about the abortion pill, known as Mifepristone. According to the research, 10.93% of women who take the pill experience serious complications such as sepsis, infection, or hemorrhaging within 45 days—a 22-fold increase compared to the 0.5% risk cited by the FDA.

The study, based on real-world insurance claims from 865,727 women, challenges previous safety assessments that relied on smaller clinical trials. Researchers urge the FDA to reinstate stronger patient safety protocols or reconsider its approval of mifepristone altogether.

Jor-El Godsey, president of our umbrella organization Heartbeat International, emphasized the importance of these findings, stating, “Women deserve care, not careless risks disguised as healthcare.”

Providing safe, compassionate pregnancy care is the very reason The Hannah Center exists. We are committed to ensuring that women have the support and resources they need to make informed, life-affirming choices. Every donation we receive makes this mission possible, allowing us to offer essential services and care to women in need. Your generosity directly changes lives and strengthens our ability to serve our community.

_{For more information, visit StopHarmingWomen.org}